Correction to Lancet Diabetes Endocrinol 2025; published online April 28. https://doi.org/10.1016/S2213-8587(25)00022-1

Abstract

Knowler WC, Doherty L, Edelstein SL, et al. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes Endocrinol 2025; published online April 28. https://doi.org/10.1016/S2213-8587(25)00022-1—In figure 1 in this Article, in the intensive lifestyle intervention arm, the number of individuals enrolled in the DPPOS should have been 916. Additionally, in the Introduction section, the final sentence of the first paragraph should have read, “…in participants treated with metformin, with an RD [rate difference] of –3·2 cases per 100 person-years”, and in the Results section, the second sentence of the third paragraph should have read, “The estimated cumulative incidence up to 21 years was 69·9%...”. Appendix 2 has also been corrected. These corrections have been made to the online versions as of May 1, 2025, and the printed version will be correct.